FDA issues quarterly list of drugs with potential safety concerns

08/29/2010 | Reuters

Roche Holding's breast cancer drug Herceptin and Sanofi-Aventis' heart drug Multaq are on the FDA's quarterly list of treatments being investigated for possible safety risks. The list also includes Pfizer's antibiotic Cleocin, Merck & Co.'s contraceptive Implanon and Novartis' cancer treatment Afinitor.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Chief Executive Officer
UCare Minnesota
Minneapolis, MN
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC